Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.
The current conflict in Iran may only have a marginal impact on the global economy, according to an opinion by stock exchange broker Investimental.
Romanian energy company Simtel Team has appointed Petre Stoian as CEO to consolidate its management structure as the group expands its operations.
The Romanian government has adopted an emergency ordinance for administrative reform that officially recognises what specialists have long signalled: public administration is oversized, fragmented and financially unsustainable, according to an opinion by PwC Romania experts Dinu Bumbăcea and Cristian Cortez.
Romania continues to lag significantly behind the European average regarding the modernisation of its rail infrastructure.
Romania's Ministry of Finance has announced a new spring edition of its Tezaur government bond programme, offering citizens attractive investment opportunities with annual interest rates reaching 7%.